Özet:

This clinical study was conducted to compare the complication rates of fluoroquinolone antibiotics such as ciprofloxacin and levofloxacin which are used to prevent infective complications that may occur after the transrectal ultrasound-guided transrectal prostate biopsy. This study was conducted between February 2009 and February 2010 at the Department of Urology, University Faculty of Medicine. One hundred sixty six patients who have abnormal digital rectal examination findings and high PSA level were included in this study. In the first group, 83 patients were given ciprofloxacin 750 mg, orally 12 and 2 hours before biopsy and 5 days (twice a day) after the biopsy. In the second group, 83 patients were given levofloxacin 500 mg, orally 12 and 2 hours before biopsy and 5 days (once a day) after the biopsy. Two groups were compared in terms of minor and major complications occured after the biopsy and the factors affecting these complications. There was no statistically significant difference between the two groups in terms of infective complications. Fourteen (8.4%) of 166 patients developed acute prostatitis and these patients were hospitalized for parenteral antibiotic treatment. Leucocyturia was seen in 10.8% of patients after the biopsy and 72.2% of these patients developed acute prostatis. Escherichia coli was isolated in all of the positive urine cultures and all of them were resistant to ciprofloxacine. Five (35.7%) of 14 patients had ESBL-positive E. Coli isolated in urine culture. Both Ciprofloxacine and levofloxacin regimens seem to be equally effective in the antibiotic prophylaxis for transrectal prostate biopsy. However, ciprofloxacin may be preferable because of lower costs

Anahtar Kelimeler: